Cell-based Assays | NMI TT Pharmaservices

home contact company.overview news sitemap print

Custom Cell Services

Contact

NMI-TT Contact Person

Dr. Frank Weise

+49 7121 51530 56




Cell-based Assays

With a long-standing commercial track record in cell-based research, we have established a wide range of cell-based assay options.

    Our portfolio:
  • A broad choice of cell lines and primary models, covering multiple disease indications (oncology, metabolic diseases, cardiovascular etc.)
  • Compound treatments, up to small libraries
  • Deep understanding and experience in gene silencing assays using shRNAs and siRNAs
  • Standard and custom homogenous plate reader assays (proliferation, apoptosis etc.)
  • Label-free impedance measurements
  • Fixed-endpoint and live high-content microscopy assays
  • Confocal microscopy and FACS analyses
  • Single and multiplexed RT-qPCR assays: Quantstudio platform for pre-designed or custom panels of up to 900 genes
  • Multiplexed protein profiling using in-house technologies (DigiWest, RPPA, Luminex)




 

Linked in profile

NMI TT is a subsidiary of NMI